Taganile, Shainelyn .
HRN: 12-83-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2024
CEFUROXIME 500MG (TAB)
06/18/2024
06/25/2024
PO
500 Mg
BID
S/P Primary Classical CS W/ Intracesarean IUD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes